Low dose TamOxifen and LifestylE changes for bReast cANcer prevention (TOLERANT study): Study protocol of a randomized phase II biomarker trial in women at increased risk for breast cancer.
Guerrieri-Gonzaga A, Serrano D, Gnagnarella P, Johansson H, Zovato S, Nardi M, Pensabene M, Buccolo S, DeCensi A, Briata IM, Pistelli L, Sansone C, Mannucci S, Aristarco V, Macis D, Lazzeroni M, Aurilio G, Accornero CA, Gandini S, Bonanni B.
Guerrieri-Gonzaga A, et al. Among authors: pistelli l.
PLoS One. 2024 Sep 3;19(9):e0309511. doi: 10.1371/journal.pone.0309511. eCollection 2024.
PLoS One. 2024.
PMID: 39226292
Free PMC article.